相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolomic analysis-Addressing NMR and LC-MS related problems in human feces sample preparation
Simon Moosmang et al.
CLINICA CHIMICA ACTA (2019)
Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study
Jeremy F. L. Cobbold et al.
HEPATOLOGY RESEARCH (2018)
Volatile metabolites in breath strongly correlate with gut microbiome in CD patients
Agnieszka Smolinska et al.
ANALYTICA CHIMICA ACTA (2018)
Oral microbiome alterations of healthy volunteers with proton pump inhibitor
Tsuyoshi Mishiro et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
The effect of sampling procedures on the urate in oral fluid and lactate concentration in oral fluid
T. Lomonaco et al.
MICROCHEMICAL JOURNAL (2018)
Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial
Bjorn Staehr Madsen et al.
TRIALS (2018)
Impact of a vegan diet on the human salivary microbiota
Tue H. Hansen et al.
SCIENTIFIC REPORTS (2018)
Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker
Kentaro Iwasawa et al.
SCIENTIFIC REPORTS (2018)
Methodology challenges in studying human gut microbiota - effects of collection, storage, DNA extraction and next generation sequencing technologies
Marina Panek et al.
SCIENTIFIC REPORTS (2018)
Microbial Eukaryotes: a Missing Link in Gut Microbiome Studies
Isabelle Laforest-Lapointe et al.
MSYSTEMS (2018)
Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot
Ahmed Abdel-Razik et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Volatile organic compound (VOC) analysis to differentiate between bacterial and viral respiratory infections in COPD
Faisal Kamal et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS
Oluwasola Lawal et al.
JOURNAL OF BREATH RESEARCH (2018)
Saliva diagnostics - Current views and directions
Karolina Elzbieta Kaczor-Urbanowicz et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Gut Microbiota Profiling of Pediatric Nonalcoholic Fatty Liver Disease and Obese Patients Unveiled by an Integrated Meta-omics-Based Approach
Federica Del Chierico et al.
HEPATOLOGY (2017)
Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using H-1 NMR-Based Metabolomics
Ali Yilmaz et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Unraveling Core Functional Microbiota in Traditional Solid-State Fermentation by High-Throughput Amplicons and Metatranscriptomics Sequencing
Zhewei Song et al.
FRONTIERS IN MICROBIOLOGY (2017)
Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial
Brooks D. Cash et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
The SALAMANDER project: SALivAry bioMarkers of mediterraneAN Diet associated with long-tERm protection against type 2 diabetes
G. B. Proctor et al.
NUTRITION BULLETIN (2017)
Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile
Kamesh Gupta et al.
CLINICAL MEDICINE INSIGHTS-GASTROENTEROLOGY (2017)
Review article: the antimicrobial effects of rifaximin on the gut microbiota
H. L. DuPont
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis
J. S. Bajaj
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin
Loris R. Lopetuso et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation
D. Weber et al.
BONE MARROW TRANSPLANTATION (2016)
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin
Francesca Romana Ponziani et al.
DIGESTIVE DISEASES (2016)
Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation
Francesca Romana Ponziani et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Salivaomics for oral diseases biomarkers detection
Jason Tasoulas et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Anthony Lembo et al.
GASTROENTEROLOGY (2016)
Salivary and fecal microbiota and metabolome of celiac children under gluten-free diet
Maria De Angelis et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2016)
Salivary Metabolite Fingerprint of Type 1 Diabetes in Young Children
Livia Roberta Piedade de Oliveira et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
John S. Kane et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2016)
High-throughput metabolomics analysis discovers salivary biomarkers for predicting mild cognitive impairment and Alzheimer's disease
Qun Liang et al.
RSC ADVANCES (2016)
In vivo solid phase microextraction sampling of human saliva for non-invasive and on-site monitoring
Vincent Bessonneau et al.
ANALYTICA CHIMICA ACTA (2015)
Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
Venkatanarayana Gangarapu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Salivary biomarkers of oxidative stress: A critical review
Jessica Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
The human saliva metabolome
Zerihun T. Dame et al.
METABOLOMICS (2015)
Measuring Breath Acetone for Monitoring Fat Loss: Review
Joseph C. Anderson
OBESITY (2015)
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications
Francesca Romana Ponziani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Evaluation of a new oral health scale of infectious potential based on the salivary microbiota
Marta Relvas et al.
CLINICAL ORAL INVESTIGATIONS (2015)
The scent of human diseases: a review on specific volatile organic compounds as diagnostic biomarkers
Fanis Buljubasic et al.
FLAVOUR AND FRAGRANCE JOURNAL (2015)
Metabolomics-based screening of salivary biomarkers for early diagnosis of Alzheimer's disease
Qun Liang et al.
RSC ADVANCES (2015)
Analytical methods in untargeted metabolomics: state of the art in 2015
Arnald Alonso et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2015)
SALIVARY METABOLOMICS OF PRIMARY SJOGREN'S SYNDROME
G. Kageyama et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Salivary Microbiota and Metabolome Associated with Celiac Disease
Ruggiero Francavilla et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy
Yuan Xu et al.
ARCHIVES OF ORAL BIOLOGY (2014)
Processing faecal samples: a step forward for standards in microbial community analysis
Alba Santiago et al.
BMC MICROBIOLOGY (2014)
ITALIAN-STYLE GLUTEN-FREE DIET CHANGES THE SALIVARY MICROBIOTA AND METABOLOME OF AFRICAN (SAHARAWI) CELIAC CHILDREN
Ruggiero Francavilla et al.
DIGESTIVE AND LIVER DISEASE (2014)
Dysbiosis of Salivary Microbiota in Inflammatory Bowel Disease and Its Association With Oral Immunological Biomarkers
Heba S. Said et al.
DNA RESEARCH (2014)
Untargeted Metabolomic Profiling in Saliva of Smokers and Nonsmokers by a Validated GC-TOF-MS Method
Daniel C. Mueller et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Saliva: A Fluid of Study for OMICS
Betzaida Cuevas-Cordoba et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2014)
The Same Microbiota and a Potentially Discriminant Metabolome in the Saliva of Omnivore, Ovo-Lacto-Vegetarian and Vegan Individuals
Francesca De Filippis et al.
PLOS ONE (2014)
Influence of Sampling on the Determination of Warfarin and Warfarin Alcohols in Oral Fluid
Tommaso Lomonaco et al.
PLOS ONE (2014)
A review of the volatiles from the healthy human body
B. de Lacy Costello et al.
JOURNAL OF BREATH RESEARCH (2014)
The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva
Anton Amann et al.
JOURNAL OF BREATH RESEARCH (2014)
An investigation of volatile organic compounds from the saliva of healthy individuals using headspace-trap/GC-MS
Huda AL-Kateb et al.
JOURNAL OF BREATH RESEARCH (2013)
Saliva Metabolomics Opens Door to Biomarker Discovery, Disease Diagnosis, and Treatment
Aihua Zhang et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2012)
Simultaneous determination of lactate and pyruvate in human sweat using reversed-phase high-performance liquid chromatography: a noninvasive approach
Simona Biagi et al.
BIOMEDICAL CHROMATOGRAPHY (2012)
Quantitative analysis of microbiota in saliva, supragingival, and subgingival plaque of Chinese adults with chronic periodontitis
Jiayan He et al.
CLINICAL ORAL INVESTIGATIONS (2012)
Volatile organic compound analysis by ion molecule reaction mass spectrometry for Gram-positive bacteria differentiation
M. E. Dolch et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Salivary biomarker development using genomic, proteomic and metabolomic approaches
Nicolai J. Bonne et al.
GENOME MEDICINE (2012)
Rifaximin in the treatment of inflammatory bowel disease
Mario Guslandi
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Saliva: reflection of the body
Daniela Pereira Lima et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Analysis of Volatile Organic Compounds in Human Saliva by a Static Sorptive Extraction Method and Gas Chromatography-Mass Spectrometry
Helena A. Soini et al.
JOURNAL OF CHEMICAL ECOLOGY (2010)
Evaluation of the Birmingham IBS symptom questionnaire
Andrea K. Roalfe et al.
BMC GASTROENTEROLOGY (2008)
Analytical strategies in metabonomics
Eva Maria Lenz et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Detection of volatile metabolites produced by bacterial growth in blood culture media by selected ion flow tube mass spectrometry (SIFT-MS)
RA Allardyce et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2006)
Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis
P Brigidi et al.
JOURNAL OF CHEMOTHERAPY (2002)
分享论文
